Accessibility of the unstructured α-tubulin C-terminal tail is controlled by microtubule lattice conformation
eLife · 2026
DOI: 10.7554/elife.109308 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Takashi Hotta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States. Hauptthemen laut MEDLINE: Tubulin, Microtubules. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, American Cancer Society.
Abstract (Originalsprache)
Microtubules are cytoskeletal filaments that self-assemble from the protein tubulin, a heterodimer of α-tubulin and β-tubulin, and are important for cell mechanics, migration, and division. Much work has focused on how the nucleotide state of β-tubulin regulates the structure and dynamics of microtubules. In contrast, less is known about the structure and function of the C-terminal tails (CTTs) of α- and β-tubulin which are thought to freely protrude from the surface of the microtubule. To study the CTT of α-tubulin, we developed three different biosensors that bind the tyrosinated α-tubulin CTT (Y-αCTT). Surprisingly, live imaging of the probes indicates that the Y-αCTT is minimally accessible along the microtubule lattice under normal cellular conditions. Lattice binding of the Y-αCTT probes can be increased by three different ways of changing the tubulin conformational state: the drug Taxol, expression of microtubule-associated proteins (MAPs) that recognize or promote an expanded tubulin conformation, or expression of tubulin that cannot hydrolyze GTP. Molecular dynamics simulations indicate that the Y-αCTT undergoes numerous transient interactions with the bodies of α-tubulin and β-tubulin in the lattice, and that the frequency of these interactions is regulated by the tubulin nucleotide state. These findings suggest that accessibility of the Y-αCTT is locally governed by nucleotide- and MAP-dependent conformational changes to tubulin subunits within the microtubule lattice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States.
- Department of Biophysics, University of Michigan, Ann Arbor, United States.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
- Department of Biological Chemistry, University of Michigan, Ann Arbor, United States.
- Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, United States.
- Graduate School of Science and Technology, Kumamoto University, Kumamoto, Japan.
ORCID-Profile: Morgan L Pimm, Ezekiel C Thomas, Patrick DeLear, Michael A Cianfrocco, Morgan E DeSantis, David Sept, Kristen J Verhey
Förderung
- NIGMS NIH HHS
- NIH HHS
- American Cancer Society
- National Institutes of Health
Zitieren
APA
Hotta, T., Pimm, M. L., Thomas, E. C., Yue, Y., DeLear, P., Blasius, L., Cianfrocco, M. A., DeSantis, M. E., Horiuchi, R., Higaki, T., Sept, D., Ohi, R., & Verhey, K. J. (2026). Accessibility of the unstructured α-tubulin C-terminal tail is controlled by microtubule lattice conformation. eLife. https://doi.org/10.7554/elife.109308
Vancouver
Hotta T, Pimm ML, Thomas EC, Yue Y, DeLear P, Blasius L, et al. Accessibility of the unstructured α-tubulin C-terminal tail is controlled by microtubule lattice conformation. eLife. 2026. doi:10.7554/elife.109308
BibTeX
@article{Hotta2026,
author = {Hotta, Takashi and Pimm, Morgan L and Thomas, Ezekiel C and Yue, Yang and DeLear, Patrick and Blasius, Lynne and Cianfrocco, Michael A and DeSantis, Morgan E and Horiuchi, Ryota and Higaki, Takumi and Sept, David and Ohi, Ryoma and Verhey, Kristen J},
title = {Accessibility of the unstructured α-tubulin C-terminal tail is controlled by microtubule lattice conformation},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.109308}
}
EUVIMED